Kuan-Wei Huang

Affiliations: 
2016-2018 Biomedical Engineering National Tsing Hua University, Hsinchu City, Taiwan, ROC 
Google:
"Kuan-Wei Huang"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Magoling BJA, Wu AY, Chen YJ, et al. (2023) Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers in vivo. Advanced Materials (Deerfield Beach, Fla.). e2208966
Chen HY, Chan SJ, Liu X, et al. (2022) Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression. Journal of Hematology & Oncology. 15: 85
Cheng HT, Huang HC, Lee TY, et al. (2022) Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 346: 169-179
Song JS, Chang CC, Wu CH, et al. (2021) A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proceedings of the National Academy of Sciences of the United States of America. 118
Huang KW, Hsu FF, Qiu JT, et al. (2020) Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Science Advances. 6: eaax5032
Huang KW, Lai YT, Chern GJ, et al. (2018) Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma. Biomacromolecules
Liu CH, Chern GG, Hsu FF, et al. (2017) A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia. Hepatology (Baltimore, Md.)
See more...